Prostate Cancer Nuclear Medicine Diagnostics Market - Global Outlook and Forecast 2024-2031

Report ID: 1567106 | Published Date: Jan 2025 | No. of Page: 64 | Base Year: 2024 | Rating: 4.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Prostate Cancer Nuclear Medicine Diagnostics Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Prostate Cancer Nuclear Medicine Diagnostics Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Prostate Cancer Nuclear Medicine Diagnostics Overall Market Size
    2.1 Global Prostate Cancer Nuclear Medicine Diagnostics Market Size: 2021 VS 2028
    2.2 Global Prostate Cancer Nuclear Medicine Diagnostics Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Prostate Cancer Nuclear Medicine Diagnostics Players in Global Market
    3.2 Top Global Prostate Cancer Nuclear Medicine Diagnostics Companies Ranked by Revenue
    3.3 Global Prostate Cancer Nuclear Medicine Diagnostics Revenue by Companies
    3.4 Top 3 and Top 5 Prostate Cancer Nuclear Medicine Diagnostics Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Prostate Cancer Nuclear Medicine Diagnostics Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Prostate Cancer Nuclear Medicine Diagnostics Players in Global Market
        3.6.1 List of Global Tier 1 Prostate Cancer Nuclear Medicine Diagnostics Companies
        3.6.2 List of Global Tier 2 and Tier 3 Prostate Cancer Nuclear Medicine Diagnostics Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Prostate Cancer Nuclear Medicine Diagnostics Market Size Markets, 2021 & 2028
        4.1.2 SPECT
        4.1.3 PET
    4.2 By Type - Global Prostate Cancer Nuclear Medicine Diagnostics Revenue & Forecasts
        4.2.1 By Type - Global Prostate Cancer Nuclear Medicine Diagnostics Revenue, 2017-2022
        4.2.2 By Type - Global Prostate Cancer Nuclear Medicine Diagnostics Revenue, 2023-2028
        4.2.3 By Type - Global Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Prostate Cancer Nuclear Medicine Diagnostics Market Size, 2021 & 2028
        5.1.2 Hospitals
        5.1.3 Clinics
        5.1.4 Others
    5.2 By Application - Global Prostate Cancer Nuclear Medicine Diagnostics Revenue & Forecasts
        5.2.1 By Application - Global Prostate Cancer Nuclear Medicine Diagnostics Revenue, 2017-2022
        5.2.2 By Application - Global Prostate Cancer Nuclear Medicine Diagnostics Revenue, 2023-2028
        5.2.3 By Application - Global Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Prostate Cancer Nuclear Medicine Diagnostics Market Size, 2021 & 2028
    6.2 By Region - Global Prostate Cancer Nuclear Medicine Diagnostics Revenue & Forecasts
        6.2.1 By Region - Global Prostate Cancer Nuclear Medicine Diagnostics Revenue, 2017-2022
        6.2.2 By Region - Global Prostate Cancer Nuclear Medicine Diagnostics Revenue, 2023-2028
        6.2.3 By Region - Global Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Prostate Cancer Nuclear Medicine Diagnostics Revenue, 2017-2028
        6.3.2 US Prostate Cancer Nuclear Medicine Diagnostics Market Size, 2017-2028
        6.3.3 Canada Prostate Cancer Nuclear Medicine Diagnostics Market Size, 2017-2028
        6.3.4 Mexico Prostate Cancer Nuclear Medicine Diagnostics Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Prostate Cancer Nuclear Medicine Diagnostics Revenue, 2017-2028
        6.4.2 Germany Prostate Cancer Nuclear Medicine Diagnostics Market Size, 2017-2028
        6.4.3 France Prostate Cancer Nuclear Medicine Diagnostics Market Size, 2017-2028
        6.4.4 U.K. Prostate Cancer Nuclear Medicine Diagnostics Market Size, 2017-2028
        6.4.5 Italy Prostate Cancer Nuclear Medicine Diagnostics Market Size, 2017-2028
        6.4.6 Russia Prostate Cancer Nuclear Medicine Diagnostics Market Size, 2017-2028
        6.4.7 Nordic Countries Prostate Cancer Nuclear Medicine Diagnostics Market Size, 2017-2028
        6.4.8 Benelux Prostate Cancer Nuclear Medicine Diagnostics Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Prostate Cancer Nuclear Medicine Diagnostics Revenue, 2017-2028
        6.5.2 China Prostate Cancer Nuclear Medicine Diagnostics Market Size, 2017-2028
        6.5.3 Japan Prostate Cancer Nuclear Medicine Diagnostics Market Size, 2017-2028
        6.5.4 South Korea Prostate Cancer Nuclear Medicine Diagnostics Market Size, 2017-2028
        6.5.5 Southeast Asia Prostate Cancer Nuclear Medicine Diagnostics Market Size, 2017-2028
        6.5.6 India Prostate Cancer Nuclear Medicine Diagnostics Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Prostate Cancer Nuclear Medicine Diagnostics Revenue, 2017-2028
        6.6.2 Brazil Prostate Cancer Nuclear Medicine Diagnostics Market Size, 2017-2028
        6.6.3 Argentina Prostate Cancer Nuclear Medicine Diagnostics Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Revenue, 2017-2028
        6.7.2 Turkey Prostate Cancer Nuclear Medicine Diagnostics Market Size, 2017-2028
        6.7.3 Israel Prostate Cancer Nuclear Medicine Diagnostics Market Size, 2017-2028
        6.7.4 Saudi Arabia Prostate Cancer Nuclear Medicine Diagnostics Market Size, 2017-2028
        6.7.5 UAE Prostate Cancer Nuclear Medicine Diagnostics Market Size, 2017-2028
7 Players Profiles
    7.1 Blue Earth Diagnostics
        7.1.1 Blue Earth Diagnostics Corporate Summary
        7.1.2 Blue Earth Diagnostics Business Overview
        7.1.3 Blue Earth Diagnostics Prostate Cancer Nuclear Medicine Diagnostics Major Product Offerings
        7.1.4 Blue Earth Diagnostics Prostate Cancer Nuclear Medicine Diagnostics Revenue in Global Market (2017-2022)
        7.1.5 Blue Earth Diagnostics Key News
    7.2 PETNET Solutions
        7.2.1 PETNET Solutions Corporate Summary
        7.2.2 PETNET Solutions Business Overview
        7.2.3 PETNET Solutions Prostate Cancer Nuclear Medicine Diagnostics Major Product Offerings
        7.2.4 PETNET Solutions Prostate Cancer Nuclear Medicine Diagnostics Revenue in Global Market (2017-2022)
        7.2.5 PETNET Solutions Key News
    7.3 Cardinal Health
        7.3.1 Cardinal Health Corporate Summary
        7.3.2 Cardinal Health Business Overview
        7.3.3 Cardinal Health Prostate Cancer Nuclear Medicine Diagnostics Major Product Offerings
        7.3.4 Cardinal Health Prostate Cancer Nuclear Medicine Diagnostics Revenue in Global Market (2017-2022)
        7.3.5 Cardinal Health Key News
    7.4 Lantheus Medical Imaging
        7.4.1 Lantheus Medical Imaging Corporate Summary
        7.4.2 Lantheus Medical Imaging Business Overview
        7.4.3 Lantheus Medical Imaging Prostate Cancer Nuclear Medicine Diagnostics Major Product Offerings
        7.4.4 Lantheus Medical Imaging Prostate Cancer Nuclear Medicine Diagnostics Revenue in Global Market (2017-2022)
        7.4.5 Lantheus Medical Imaging Key News
    7.5 Jubilant Pharma
        7.5.1 Jubilant Pharma Corporate Summary
        7.5.2 Jubilant Pharma Business Overview
        7.5.3 Jubilant Pharma Prostate Cancer Nuclear Medicine Diagnostics Major Product Offerings
        7.5.4 Jubilant Pharma Prostate Cancer Nuclear Medicine Diagnostics Revenue in Global Market (2017-2022)
        7.5.5 Jubilant Pharma Key News
    7.6 NCM-USA
        7.6.1 NCM-USA Corporate Summary
        7.6.2 NCM-USA Business Overview
        7.6.3 NCM-USA Prostate Cancer Nuclear Medicine Diagnostics Major Product Offerings
        7.6.4 NCM-USA Prostate Cancer Nuclear Medicine Diagnostics Revenue in Global Market (2017-2022)
        7.6.5 NCM-USA Key News
    7.7 Progenics Pharma
        7.7.1 Progenics Pharma Corporate Summary
        7.7.2 Progenics Pharma Business Overview
        7.7.3 Progenics Pharma Prostate Cancer Nuclear Medicine Diagnostics Major Product Offerings
        7.7.4 Progenics Pharma Prostate Cancer Nuclear Medicine Diagnostics Revenue in Global Market (2017-2022)
        7.7.5 Progenics Pharma Key News
    7.8 Telix Pharma
        7.8.1 Telix Pharma Corporate Summary
        7.8.2 Telix Pharma Business Overview
        7.8.3 Telix Pharma Prostate Cancer Nuclear Medicine Diagnostics Major Product Offerings
        7.8.4 Telix Pharma Prostate Cancer Nuclear Medicine Diagnostics Revenue in Global Market (2017-2022)
        7.8.5 Telix Pharma Key News
    7.9 ImaginAb
        7.9.1 ImaginAb Corporate Summary
        7.9.2 ImaginAb Business Overview
        7.9.3 ImaginAb Prostate Cancer Nuclear Medicine Diagnostics Major Product Offerings
        7.9.4 ImaginAb Prostate Cancer Nuclear Medicine Diagnostics Revenue in Global Market (2017-2022)
        7.9.5 ImaginAb Key News
    7.10 Theragnostics
        7.10.1 Theragnostics Corporate Summary
        7.10.2 Theragnostics Business Overview
        7.10.3 Theragnostics Prostate Cancer Nuclear Medicine Diagnostics Major Product Offerings
        7.10.4 Theragnostics Prostate Cancer Nuclear Medicine Diagnostics Revenue in Global Market (2017-2022)
        7.10.5 Theragnostics Key News
    7.11 Novartis
        7.11.1 Novartis Corporate Summary
        7.11.2 Novartis Business Overview
        7.11.3 Novartis Prostate Cancer Nuclear Medicine Diagnostics Major Product Offerings
        7.11.4 Novartis Prostate Cancer Nuclear Medicine Diagnostics Revenue in Global Market (2017-2022)
        7.11.5 Novartis Key News
    7.12 Alliance Medical
        7.12.1 Alliance Medical Corporate Summary
        7.12.2 Alliance Medical Business Overview
        7.12.3 Alliance Medical Prostate Cancer Nuclear Medicine Diagnostics Major Product Offerings
        7.12.4 Alliance Medical Prostate Cancer Nuclear Medicine Diagnostics Revenue in Global Market (2017-2022)
        7.12.5 Alliance Medical Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Prostate Cancer Nuclear Medicine Diagnostics Market Opportunities & Trends in Global Market
    Table 2. Prostate Cancer Nuclear Medicine Diagnostics Market Drivers in Global Market
    Table 3. Prostate Cancer Nuclear Medicine Diagnostics Market Restraints in Global Market
    Table 4. Key Players of Prostate Cancer Nuclear Medicine Diagnostics in Global Market
    Table 5. Top Prostate Cancer Nuclear Medicine Diagnostics Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Prostate Cancer Nuclear Medicine Diagnostics Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Prostate Cancer Nuclear Medicine Diagnostics Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Prostate Cancer Nuclear Medicine Diagnostics Product Type
    Table 9. List of Global Tier 1 Prostate Cancer Nuclear Medicine Diagnostics Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Prostate Cancer Nuclear Medicine Diagnostics Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Prostate Cancer Nuclear Medicine Diagnostics Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Prostate Cancer Nuclear Medicine Diagnostics Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Prostate Cancer Nuclear Medicine Diagnostics Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Prostate Cancer Nuclear Medicine Diagnostics Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Prostate Cancer Nuclear Medicine Diagnostics Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Prostate Cancer Nuclear Medicine Diagnostics Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Prostate Cancer Nuclear Medicine Diagnostics Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Prostate Cancer Nuclear Medicine Diagnostics Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Prostate Cancer Nuclear Medicine Diagnostics Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Prostate Cancer Nuclear Medicine Diagnostics Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Prostate Cancer Nuclear Medicine Diagnostics Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Prostate Cancer Nuclear Medicine Diagnostics Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Prostate Cancer Nuclear Medicine Diagnostics Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Prostate Cancer Nuclear Medicine Diagnostics Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Prostate Cancer Nuclear Medicine Diagnostics Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Prostate Cancer Nuclear Medicine Diagnostics Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Prostate Cancer Nuclear Medicine Diagnostics Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Revenue, (US$, Mn), 2023-2028
    Table 30. Blue Earth Diagnostics Corporate Summary
    Table 31. Blue Earth Diagnostics Prostate Cancer Nuclear Medicine Diagnostics Product Offerings
    Table 32. Blue Earth Diagnostics Prostate Cancer Nuclear Medicine Diagnostics Revenue (US$, Mn), (2017-2022)
    Table 33. PETNET Solutions Corporate Summary
    Table 34. PETNET Solutions Prostate Cancer Nuclear Medicine Diagnostics Product Offerings
    Table 35. PETNET Solutions Prostate Cancer Nuclear Medicine Diagnostics Revenue (US$, Mn), (2017-2022)
    Table 36. Cardinal Health Corporate Summary
    Table 37. Cardinal Health Prostate Cancer Nuclear Medicine Diagnostics Product Offerings
    Table 38. Cardinal Health Prostate Cancer Nuclear Medicine Diagnostics Revenue (US$, Mn), (2017-2022)
    Table 39. Lantheus Medical Imaging Corporate Summary
    Table 40. Lantheus Medical Imaging Prostate Cancer Nuclear Medicine Diagnostics Product Offerings
    Table 41. Lantheus Medical Imaging Prostate Cancer Nuclear Medicine Diagnostics Revenue (US$, Mn), (2017-2022)
    Table 42. Jubilant Pharma Corporate Summary
    Table 43. Jubilant Pharma Prostate Cancer Nuclear Medicine Diagnostics Product Offerings
    Table 44. Jubilant Pharma Prostate Cancer Nuclear Medicine Diagnostics Revenue (US$, Mn), (2017-2022)
    Table 45. NCM-USA Corporate Summary
    Table 46. NCM-USA Prostate Cancer Nuclear Medicine Diagnostics Product Offerings
    Table 47. NCM-USA Prostate Cancer Nuclear Medicine Diagnostics Revenue (US$, Mn), (2017-2022)
    Table 48. Progenics Pharma Corporate Summary
    Table 49. Progenics Pharma Prostate Cancer Nuclear Medicine Diagnostics Product Offerings
    Table 50. Progenics Pharma Prostate Cancer Nuclear Medicine Diagnostics Revenue (US$, Mn), (2017-2022)
    Table 51. Telix Pharma Corporate Summary
    Table 52. Telix Pharma Prostate Cancer Nuclear Medicine Diagnostics Product Offerings
    Table 53. Telix Pharma Prostate Cancer Nuclear Medicine Diagnostics Revenue (US$, Mn), (2017-2022)
    Table 54. ImaginAb Corporate Summary
    Table 55. ImaginAb Prostate Cancer Nuclear Medicine Diagnostics Product Offerings
    Table 56. ImaginAb Prostate Cancer Nuclear Medicine Diagnostics Revenue (US$, Mn), (2017-2022)
    Table 57. Theragnostics Corporate Summary
    Table 58. Theragnostics Prostate Cancer Nuclear Medicine Diagnostics Product Offerings
    Table 59. Theragnostics Prostate Cancer Nuclear Medicine Diagnostics Revenue (US$, Mn), (2017-2022)
    Table 60. Novartis Corporate Summary
    Table 61. Novartis Prostate Cancer Nuclear Medicine Diagnostics Product Offerings
    Table 62. Novartis Prostate Cancer Nuclear Medicine Diagnostics Revenue (US$, Mn), (2017-2022)
    Table 63. Alliance Medical Corporate Summary
    Table 64. Alliance Medical Prostate Cancer Nuclear Medicine Diagnostics Product Offerings
    Table 65. Alliance Medical Prostate Cancer Nuclear Medicine Diagnostics Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Prostate Cancer Nuclear Medicine Diagnostics Segment by Type in 2021
    Figure 2. Prostate Cancer Nuclear Medicine Diagnostics Segment by Application in 2021
    Figure 3. Global Prostate Cancer Nuclear Medicine Diagnostics Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Prostate Cancer Nuclear Medicine Diagnostics Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Prostate Cancer Nuclear Medicine Diagnostics Revenue in 2021
    Figure 8. By Type - Global Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Share, 2017-2028
    Figure 12. US Prostate Cancer Nuclear Medicine Diagnostics Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Prostate Cancer Nuclear Medicine Diagnostics Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Prostate Cancer Nuclear Medicine Diagnostics Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Share, 2017-2028
    Figure 16. Germany Prostate Cancer Nuclear Medicine Diagnostics Revenue, (US$, Mn), 2017-2028
    Figure 17. France Prostate Cancer Nuclear Medicine Diagnostics Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Prostate Cancer Nuclear Medicine Diagnostics Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Prostate Cancer Nuclear Medicine Diagnostics Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Prostate Cancer Nuclear Medicine Diagnostics Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Prostate Cancer Nuclear Medicine Diagnostics Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Prostate Cancer Nuclear Medicine Diagnostics Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Share, 2017-2028
    Figure 24. China Prostate Cancer Nuclear Medicine Diagnostics Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Prostate Cancer Nuclear Medicine Diagnostics Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Prostate Cancer Nuclear Medicine Diagnostics Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Prostate Cancer Nuclear Medicine Diagnostics Revenue, (US$, Mn), 2017-2028
    Figure 28. India Prostate Cancer Nuclear Medicine Diagnostics Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Share, 2017-2028
    Figure 30. Brazil Prostate Cancer Nuclear Medicine Diagnostics Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Prostate Cancer Nuclear Medicine Diagnostics Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Share, 2017-2028
    Figure 33. Turkey Prostate Cancer Nuclear Medicine Diagnostics Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Prostate Cancer Nuclear Medicine Diagnostics Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Prostate Cancer Nuclear Medicine Diagnostics Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Prostate Cancer Nuclear Medicine Diagnostics Revenue, (US$, Mn), 2017-2028
    Figure 37. Blue Earth Diagnostics Prostate Cancer Nuclear Medicine Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. PETNET Solutions Prostate Cancer Nuclear Medicine Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Cardinal Health Prostate Cancer Nuclear Medicine Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Lantheus Medical Imaging Prostate Cancer Nuclear Medicine Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Jubilant Pharma Prostate Cancer Nuclear Medicine Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. NCM-USA Prostate Cancer Nuclear Medicine Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Progenics Pharma Prostate Cancer Nuclear Medicine Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Telix Pharma Prostate Cancer Nuclear Medicine Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. ImaginAb Prostate Cancer Nuclear Medicine Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Theragnostics Prostate Cancer Nuclear Medicine Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 47. Novartis Prostate Cancer Nuclear Medicine Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 48. Alliance Medical Prostate Cancer Nuclear Medicine Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
64
Frequently Asked Questions
Prostate Cancer Nuclear Medicine Diagnostics Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Prostate Cancer Nuclear Medicine Diagnostics Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Prostate Cancer Nuclear Medicine Diagnostics Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports